Advertisement
Advertisement

DWTX

D

Dogwood Therapeutics Inc.

2.61
USD
+0.27
+11.54%
Dec 18, 11:24 UTC -5
Open

Dogwood Therapeutics Inc. Profile

About

Dogwood Therapeutics Inc. is a biopharmaceutical company. It engages in developing a new class of non-opioid analgesics. The company focuses on the development of Halneuron, IMC-1 and IMC-2. Dogwood Therapeutics Inc., formerly known as Virios Therapeutics Inc., is based in Alpharetta, GA.

Info & Links

CEO

Greg Duncan

Headquarters

44 MILTON AVENUE
ALPHARETTA, GA 30009, UNITED STATES

Auditor

FORVIS LLP

Share holders

131

Employees

4

Dogwood Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization2

3.47M

Enterprise Value

1.43M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.76

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-217.12%

Return on Invested Capital(ttm)

-351.32%

Return on Assets(ttm)

-172.06%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-5.82M

Net Income Available to Common(ttm)

-5.72M

Diluted EPS(ttm)

-6.55

Share Statistics

Beta (5Y Monthly)

1.32

52-Week Change

-85.85%

S&P 500 52-Week Change

25.95%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.33M

Dividend Yield

0.00%

Float4

1.17M

% Held by Insiders

12.20%

% Held by Institutions

9.05%

Balance Sheet

Total Cash(mrq)

2.04M

Total Cash Per Share(mrq)

1.53

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.71%

Quick Ratio(mrq)

1.71%

Book Value Per Share(mrq)

0.86

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.40

Free Cash Flow(ytd)

-2.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement